JP2013507934A5 - - Google Patents

Download PDF

Info

Publication number
JP2013507934A5
JP2013507934A5 JP2012534410A JP2012534410A JP2013507934A5 JP 2013507934 A5 JP2013507934 A5 JP 2013507934A5 JP 2012534410 A JP2012534410 A JP 2012534410A JP 2012534410 A JP2012534410 A JP 2012534410A JP 2013507934 A5 JP2013507934 A5 JP 2013507934A5
Authority
JP
Japan
Prior art keywords
cell
minivector
nucleic acid
acid sequence
gene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2012534410A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013507934A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2010/052920 external-priority patent/WO2011047318A2/en
Publication of JP2013507934A publication Critical patent/JP2013507934A/ja
Publication of JP2013507934A5 publication Critical patent/JP2013507934A5/ja
Pending legal-status Critical Current

Links

JP2012534410A 2009-10-16 2010-10-15 遺伝子療法適用のためのスーパーコイル状ミニサークルdna Pending JP2013507934A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US25245509P 2009-10-16 2009-10-16
US61/252,455 2009-10-16
PCT/US2010/052920 WO2011047318A2 (en) 2009-10-16 2010-10-15 Supercoiled minicircle dna for gene therapy applications

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2016214390A Division JP2017046710A (ja) 2009-10-16 2016-11-01 遺伝子療法適用のためのスーパーコイル状ミニサークルdna

Publications (2)

Publication Number Publication Date
JP2013507934A JP2013507934A (ja) 2013-03-07
JP2013507934A5 true JP2013507934A5 (enExample) 2013-12-05

Family

ID=43876905

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2012534410A Pending JP2013507934A (ja) 2009-10-16 2010-10-15 遺伝子療法適用のためのスーパーコイル状ミニサークルdna
JP2016214390A Pending JP2017046710A (ja) 2009-10-16 2016-11-01 遺伝子療法適用のためのスーパーコイル状ミニサークルdna

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2016214390A Pending JP2017046710A (ja) 2009-10-16 2016-11-01 遺伝子療法適用のためのスーパーコイル状ミニサークルdna

Country Status (10)

Country Link
US (3) US8460924B2 (enExample)
EP (1) EP2488641B1 (enExample)
JP (2) JP2013507934A (enExample)
KR (1) KR20120094166A (enExample)
AU (1) AU2010306645B2 (enExample)
BR (1) BR112012011576A2 (enExample)
CA (1) CA2777835A1 (enExample)
MX (1) MX2012004447A (enExample)
NZ (1) NZ599998A (enExample)
WO (1) WO2011047318A2 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101510830B1 (ko) 2012-05-11 2015-04-10 가톨릭대학교 산학협력단 생리활성 단백질을 발현하는 미니서클을 이용하여 형질전환된 줄기세포를 통한 치료법
JP2015523860A (ja) * 2012-05-30 2015-08-20 ベイラー カレッジ オブ メディスンBaylor College Of Medicine DNAの修復、変更および置き換えのための道具としてのスーパーコイルMiniVector
EP2735614A1 (en) * 2012-11-22 2014-05-28 Centre National De La Recherche Scientifique In vitro production of DNA minicircles comprising less than 250 base pairs
US10604771B2 (en) 2013-05-10 2020-03-31 Sangamo Therapeutics, Inc. Delivery methods and compositions for nuclease-mediated genome engineering
GB201702500D0 (en) * 2017-02-16 2017-04-05 Univ Sheffield Stable vamp reporter assay
US20180305701A1 (en) 2017-03-14 2018-10-25 Baylor College Of Medicine Targeting minivectors to specific tissue using shape
US20200048716A1 (en) 2017-11-03 2020-02-13 Twister Biotech, Inc Using minivectors to treat ovarian cancer
GB2700048B (en) 2019-09-18 2026-03-04 Aldevron Llc synthetic dna vectors and method of use
US20240093226A1 (en) 2021-09-10 2024-03-21 Baylor College Of Medicine Ultrapure minivectors for gene therapy
US20240100189A1 (en) 2021-09-10 2024-03-28 Twister Biotech, Inc Using minivectors to treat idiopathic pulmonary fibrosis
US20230190955A1 (en) 2021-10-21 2023-06-22 Baylor College Of Medicine Treatment of liver cancer or liver fibrosis

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2626584B1 (fr) * 1988-01-28 1990-07-13 Agronomique Inst Nat Rech Sequence ars efficace chez yarrowia lipolytica et procede pour sa preparation
AU5405994A (en) 1992-10-16 1994-05-09 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Supercoiled minicircle dna as as a unitary promoter vector
US6964861B1 (en) * 1998-11-13 2005-11-15 Invitrogen Corporation Enhanced in vitro recombinational cloning of using ribosomal proteins
WO2003103600A2 (en) 2002-06-05 2003-12-18 Invitrogen Corporation Methods and compositions for synthesis of nucleic acid molecules using multiple recognition sites
EP1349917B1 (en) 2000-12-08 2010-03-10 Life Technologies Corporation Methods and compositions for synthesis of nucleic acid molecules using multiple recognition sites
AU2002247848A1 (en) 2001-04-10 2002-10-28 Imperial College Innovations Limited Methods for the production of minicircles
GB0108968D0 (en) * 2001-04-10 2001-05-30 Imp College Innovations Ltd Methods
WO2003064623A2 (en) 2002-01-31 2003-08-07 Washington State University Research Foundation Methods and vectors for facilitating site-specific recombination
WO2004020605A2 (en) 2002-08-29 2004-03-11 The Board Of Trustees Of The Leland Stanford Junior University Circular nucleic acid vectors, and methods for making and using the same
US7288529B2 (en) 2003-04-24 2007-10-30 New York University ALK protein tyrosine kinase, cells and methods embodying and using same
EP1631672B1 (de) * 2003-06-10 2006-09-20 Mologen AG Zirkuläres expressionskonstrukt für gentherapeutische anwendungen
JP2008526229A (ja) * 2005-01-06 2008-07-24 ベニテック,インコーポレーテッド 幹細胞の維持のためのRNAi剤
US7622252B2 (en) * 2005-06-10 2009-11-24 Baylor College Of Medicine Generation of minicircle DNA with physiological supercoiling
US20070258952A1 (en) * 2006-05-04 2007-11-08 Baylor Research Institute Anti-Tumor Activity of an Oncolytic Adenovirus-Delivered Oncogene siRNA
WO2009018500A1 (en) * 2007-07-31 2009-02-05 The Johns Hopkins University Polypeptide-nucleic acid conjugate for immunoprophylaxis or immunotherapy for neoplastic or infectious disorders

Similar Documents

Publication Publication Date Title
JP2013507934A5 (enExample)
Jansson et al. MicroRNA and cancer
JP2012520085A5 (enExample)
JP2009519339A5 (enExample)
JP2018522566A5 (enExample)
JP2011525793A5 (enExample)
GEP201606544B (en) Excision of transgenes in genetically modified organisms
JP2017524348A5 (enExample)
JP2019524140A5 (enExample)
EP4227415A3 (en) Capsid-free aav vectors, compositions, and methods for vector production and gene delivery
JP2015533297A5 (enExample)
JP2017510542A5 (enExample)
JP2010500029A5 (enExample)
AR072680A1 (es) Axmi-115 axmi-113 axmi-005 axmi-163 y axmi-184 proteinas insecticidas y metodos de uso de las mismas
JP2019527563A5 (enExample)
JP2013544511A5 (enExample)
JP2010523099A5 (enExample)
WO2010014857A3 (en) Chromosome therapy
JP2010532656A5 (enExample)
JP2016500260A5 (enExample)
WO2019117714A8 (en) Methods for preparing nucleic acid molecules for sequencing
JP2011520424A5 (enExample)
JP2011504375A5 (enExample)
WO2015175732A3 (en) Recurrent fusion genes in human cancers
JP2014521312A5 (enExample)